United Therapeutics Corporation shares owned by Legal & General Group
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $62M | 280k | 219.89 |
| 2023-09-30 | $50M | 220k | 225.87 |
| 2023-06-30 | $49M | 222k | 220.75 |
| 2023-03-31 | $49M | 217k | 223.96 |
| 2022-12-31 | $34M | 121k | 278.09 |
| 2022-09-30 | $24M | 115k | 209.38 |
| 2022-06-30 | $28M | 119k | 235.64 |
| 2022-03-31 | $22M | 120k | 179.41 |
| 2021-12-31 | $25M | 118k | 216.08 |
| 2021-09-30 | $21M | 115k | 184.62 |
| 2021-06-30 | $21M | 114k | 179.48 |
| 2021-03-31 | $22M | 130k | 167.34 |
| 2020-12-31 | $20M | 131k | 151.81 |
| 2020-09-30 | $14M | 138k | 101.01 |
| 2020-06-30 | $16M | 135k | 121.08 |
| 2020-03-31 | $12M | 125k | 94.82 |
| 2019-12-31 | $11M | 127k | 88.08 |
| 2019-09-30 | $9.7M | 122k | 79.29 |
| 2019-06-30 | $8.9M | 114k | 78.08 |
| 2019-03-31 | $19M | 164k | 117.19 |
| 2018-12-31 | $12M | 113k | 108.95 |
| 2018-09-30 | $13M | 101k | 127.91 |
| 2018-06-30 | $11M | 99k | 113.66 |
| 2018-03-31 | $11M | 99k | 112.45 |
| 2017-12-31 | $14M | 92k | 147.96 |
| 2017-09-30 | $11M | 90k | 117.18 |
| 2017-06-30 | $11M | 81k | 129.75 |
| 2017-03-31 | $9.7M | 72k | 135.37 |
| 2016-12-31 | $7.4M | 52k | 143.44 |
| 2016-09-30 | $5.2M | 44k | 118.17 |
| 2016-06-30 | $4.4M | 41k | 105.87 |
| 2016-03-31 | $3.5M | 32k | 111.23 |
| 2015-12-31 | $4.3M | 28k | 156.53 |
| 2015-09-30 | $3.5M | 26k | 131.13 |
| 2015-06-30 | $3.8M | 22k | 173.66 |
| 2015-03-31 | $467k | 2.7k | 172.32 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation